ReviewCancer diagnosis & prognosis

Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.

Anna Karolyna DA Costa Machado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.